Skip to main content
MLTX
NASDAQ Life Sciences

MoonLake Immunotherapeutics Prices Upsized $200M Offering at $20/Share

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$21.25
Mkt Cap
$1.562B
52W Low
$5.95
52W High
$62.75
52W Position info
257% above low
Off High info
66% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

MLTX has more than doubled off its 52-week low of $5.95.

Summary

MoonLake Immunotherapeutics priced an upsized public offering, raising $200 million by selling 9 million Class A shares at $20 each. This capital raise follows the company's announcement of highly positive Week 52 Phase 3 clinical trial results for sonelokimab on June 22nd, and a preliminary offering launched on the same day. The $200 million infusion is a material capital raise for the company, providing significant funding to advance sonelokimab towards potential commercialization. The offering was upsized from an initial $150 million, suggesting robust investor demand, although the pricing at $20 per share is below the current market price, causing dilution for existing shareholders. The company has a Q3 2026 BLA submission target for sonelokimab.

At the time of this announcement, MLTX was trading at $21.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $5.95 to $62.75. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MLTX - Latest Insights

MLTX
Nov 04, 2026, 7:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.62
Real-time Price: $10.75 info
Change: -$0.870 (-7%) info
Market Cap: $919.152M info
MLTX
Nov 04, 2026, 7:07 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $10.75 info
Change: -$0.860 (-7%) info
Market Cap: $919.152M info
MLTX
Sep 30, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.81
Real-time Price: $10.75 info
Change: -$1.06 (-9%) info
Market Cap: $919.152M info
MLTX
Aug 10, 2026, 1:21 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $17.11
Real-time Price: $10.75 info
Change: -$6.36 (-37%) info
Market Cap: $919.152M info
MLTX
Aug 10, 2026, 7:46 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.19
Real-time Price: $10.75 info
Change: -$5.44 (-34%) info
Market Cap: $919.152M info